trending Market Intelligence /marketintelligence/en/news-insights/trending/aoshxwffhvorx7dlmuwkaw2 content esgSubNav
In This List

Arcus Biosciences closes $138M IPO

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management


Arcus Biosciences closes $138M IPO

Arcus Biosciences Inc. closed its IPO of 8 million common shares priced at $15 apiece to raise $138 million in gross proceeds.

The underwriters fully exercised their overallotment option to buy an additional 1.2 million shares.

Citigroup, Goldman Sachs & Co. LLC and Leerink Partners acted as joint book-running managers for the offering.